Momenta Pharmaceuticals, Inc. (MNTA)

[Regulardoc]

The damages question is an interesting one and I would expect that quite a bit of the testimony and cross addressed this. Regarding AMPH and its position that they could have performed the analysis overseas, well, they did not.

As far as TEVA is concerned and regarding possible damages, does anybody recall the time interval from when AMPH received approval and when TEVA received its approval?

Clearly many other moving parts, particularly the orals.